Biotech News
Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure
– Loop Diuretic Route of Administration Option Is Delivered As A Single-Use Nasal Spray – – Nasal Route Offers a Direct Path to Systemic Absorption Without Relying on the GI Tract – ANN ARBOR, Mich., Sept. 30, 2026 (GLOBE NEWSWIRE) -- With more than six million Americans living with heart failure